Tumor Microenvironment–Activated Nanostructure to Enhance MRI Capability and Nanozyme Activity for Highly Tumor‐Specific Multimodal Theranostics
Small · 2024
DOI: 10.1002/smll.202306446 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2024. Verfasst von Wenteng Xie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031…. Hauptthemen laut MEDLINE: Nanostructures, Neoplasms. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Key Research and Development Program of Shandong Province, National Natural Science Foundation of China, Taishan Scholars Construction Engineering.
Abstract (Originalsprache)
Copper‐based nanozymes exhibit excellent antitumor activity but are easily inactivated due to the disturbance of proteins or other macromolecules with sulfhydryl. A tumor microenvironment‐responsive CuMnO@Fe 3 O 4 (CMF) core–shell nanozyme for highly efficient tumor theranostics is developed. A platelet‐derived growth factor receptor‐β‐recognizing cyclic peptide (PDGFB) target is conjugated to the surface of CMF to fabricate a tumor‐specific nanozyme (PCMF). The core–shell nanostructure significantly avoids the oxidation and inactivation of copper‐based nanozyme, promoting the antitumor activity of PCMF. The weak acid‐ and GSH‐activated T 1 and T 2 relaxation rate of PCMF contributes to T 1 and T 2 dual contrast imaging at the tumor site. In addition, the PCMF disintegrates and produces some metal ions that possess Fenton catalytic activity (i.e., Cu + , Mn 2+ , and Fe 2+ ) under TME. This process significantly depletes GSH, accelerates Fenton and Fenton‐like reactions, enhances cellular reactive oxygen species (ROS) levels, and induces cancer cell apoptosis and ferroptosis. PCMF also exhibits photothermal functions, so it can be used in combined photothermal therapy, ferroptosis therapy, and chemodynamic therapy, improving anticancer activity. This work provides insights into the design of an exquisite nanostructure for high‐sensitive and tumor‐specific theranostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of High Magnetic Field and Ion Beam Physical Biology, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, 230031, P. R. China.
- University of Science and Technology of China, Hefei, 230026, P. R. China.
- High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei, Anhui, 230031, China.
- Stomatologic Hospital and College, Key Laboratory of Oral Diseases Research of Anhui Province, Anhui Medical University, Hefei, 230032, P.R. China.
- School of Pharmacy, Shandong Technology Innovation Center of Molecular Targeting and Intelligent Diagnosis and Treatment, Binzhou Medical University, Yantai, 264003, P. R. China.
ORCID-Profile: Guilong Zhang
Förderung
- Key Research and Development Program of Shandong Province
- National Natural Science Foundation of China
- Taishan Scholars Construction Engineering
- Natural Science Foundation of Shandong Province
- School Foundation of Anhui Medical University
- Key Technology Research and Development Program of Shandong Province
Zitieren
APA
Xie, W., Gan, Y., Wang, L., Si, Y., Li, Q., Song, T., Wei, P., Wu, Z., & Zhang, G. (2024). Tumor Microenvironment–Activated Nanostructure to Enhance MRI Capability and Nanozyme Activity for Highly Tumor‐Specific Multimodal Theranostics. Small. https://doi.org/10.1002/smll.202306446
Vancouver
Xie W, Gan Y, Wang L, Si Y, Li Q, Song T, et al. Tumor Microenvironment–Activated Nanostructure to Enhance MRI Capability and Nanozyme Activity for Highly Tumor‐Specific Multimodal Theranostics. Small. 2024. doi:10.1002/smll.202306446
BibTeX
@article{Xie2024,
author = {Xie, Wenteng and Gan, Yuehao and Wang, Lulu and Si, Yuanchun and Li, Qingdong and Song, Tianwei and Wei, Pengfei and Wu, Zhengyan and Zhang, Guilong},
title = {Tumor Microenvironment–Activated Nanostructure to Enhance MRI Capability and Nanozyme Activity for Highly Tumor‐Specific Multimodal Theranostics},
journal = {Small},
year = {2024},
doi = {10.1002/smll.202306446}
}
EUVIMED